Prognostic factors for COPD patients with chronic hypercapnic respiratory failure and home ventilation possible implications for daily routine;Prognosefaktoren bei Patienten mit COPD mit chronisch-hyperkapnischer respiratorischer Insuffizienz und außerklinischer Beatmungstherapie Mögliche Implikationen für die tägliche Praxis

Pneumologie

Volumn 63, Issue 9, 2009, Pages 484-491

  Budweiser, S ^a   Jorres R A ^b   Heinemann, F ^a   Pfeifer, M ^a,c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; HUMAN; HYPERCAPNIA; LUNG INSUFFICIENCY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; WEANING;

CHRONIC DISEASE; COMORBIDITY; GERMANY; HOME CARE SERVICES; HUMANS; HYPERCAPNIA; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350460207     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0029-1214993     Document Type: Review

References (71)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773
2. Budweiser S, Jorres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis 2008; 3: 605-618
3. Magnussen H, Kirsten AM, Kohler D et al. Leitlinien zur Langzeit-Sauerstofftherapie. Deutsche Gesellschaft fü r Pneumologie und Beatmungsmedizin e. V. [Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine]. Pneumologie 2008; 62: 748-756
4. Budweiser S, Jorres RA, Pfeifer M. Noninvasive home ventilation for chronic obstructive pulmonary disease: indications, utility and outcome. Curr Opin Pulm Med 2008; 14: 128-134
5. Lloyd-Owen SJ, Donaldson GC, Ambrosino N et al. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005; 25: 1025-1031
6. Budweiser S, Jorres RA, Riedl T et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninva- sive home ventilation. Chest 2007; 131: 1650-1658 (Pubitemid 46981616)
7. Nickol AH, Hart N, Hopkinson NS et al. Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis 2008; 3: 453-462
8. Windisch W, Dreher M, Storre JH et al. Nocturnal non-invasive positive pressure ventilation: physiological effects on spontaneous breathing. Respir Physiol Neurobiol 2006; 150: 251-260
9. Windisch W, Haenel M, Storre JH et al. High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD. Int J Med Sci 2009; 6: 72-76
10. Windisch W. Impact of home mechanical ventilation on health-related quality of life. Eur Respir J 2008; 32: 1328-1336
11. Tuggey JM, Plant PK, Elliott MW. Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax 2003; 58: 867-871
12. Budweiser S, Hitzl AP, Jö rres RA. Impact of noninvasive home ventilation on long-term survival in chronic hypercapnic respiratory failure: a prospective observational study. Int J Clin Pract 2007; 61: 1516-1522 (Pubitemid 47228603)
13. Casanova C, Celli BR, Tost L et al. Long-term controlled trial ofnocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118: 1582-1590
14. Clini E, Sturani C, Rossi A et al. The Italian multicentre study on nonin- vasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538
15. McEvoy RD, Pierce RJ, Hillman D et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009; 64: 561-566
16. Roussos C, Koutsoukou A. Respiratory failure. Eur Respir J Suppl 2003; 47: 3s - 14s
17. Aida A, Miyamoto K, Nishimura M et al. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med 1998; 158: 188-193
18. Chailleux E, Fauroux B, Binet F et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10- year analysis of ANTADIR Observatory. Chest 1996; 109: 741-749
19. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 1987; 42: 105-110
20. Nizet TA, van den Elshout FJ, Heijdra YF et al. Survival of chronic hyper- capnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest 2005; 127: 1904-1910
21. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012
22. Casanova C, Cote C, de Torres JP et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597
23. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123: 1460-1466
24. Martinez FJ, Foster G, Curtis JL et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334
25. Schols AM, Broekhuizen R, Weling-Scheepers CA et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59
26. Vestbo J, Prescott E, Almdal T et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83
27. Chambellan A, Chailleux E, Similowski T. Prognostic value of the hema- tocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128: 1201-1208
28. Cote C, Zilberberg MD, Mody SH et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29: 923 - 929
29. Similowski T, Agusti A, MacNee W et al. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006; 27: 390-396
30. Budweiser S, Heidtkamp F, Jorres RA et al. Predictive significance of six- minute walk distance for long-term survival in chronic hypercapnic respiratory failure. Respiration 2008; 75: 418-426
31. Oga T, Nishimura K, Tsukino M et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549
32. Watz H, Waschki B, Boehme C et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177: 743-751
33. de Torres JP, Cote CG, Lopez MV et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009; 33: 528-535
34. Mahler DA, Wells CK. Evaluating clinical methods for rating dyspnea. Chest 1988; 93: 580-586
35. Nishimura K, Izumi T, Tsukino M et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440
36. Budweiser S, Hitzl AP, Joerres RA et al. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res 2007; 8: 92
37. de Voogd JN, Wempe JB, Koeter GH et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135: 619-625
38. Ng TP, Niti M, Tan WC et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67
39. Criee CP. Empfehlungen der Deutschen Atemwegsliga zur Messung der inspiratorischen Muskelfunktion [Recommendations of the German Airway League (Deutsche Atemwegsliga) for the determination of in- spiratory muscle function]. Pneumologie 2003; 57: 98-100
40. Budweiser S, Jorres RA, Criee CP et al. Prognostic value of mouth occlusion pressure in patients with chronic ventilatory failure. Respir Med 2007; 101: 2343-2351
41. Sin DD, Anthonisen NR, Soriano JB et al. Mortality in COPD: Role of comorbidities. Eur Respir J 2006; 28: 1245-1257
42. Dahl M, Vestbo J, Lange P et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 250-255 (Pubitemid 46203128)
43. Bozinovski S, Hutchinson A, Thompson M et al. Serum amyloid a is a bio- marker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 269-278
44. Man SF, Xing L, Connett JE et al. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J 2008; 32: 1451-1457
45. Budweiser S, Luchner A, Jorres RA et al. NT-proBNP in chronic hypercapnic respiratory failure: A marker of disease severity, treatment effect and prognosis. Respir Med 2007; 101: 2003-2010
46. Oswald-Mammosser M, Weitzenblum E, Quoix E et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995; 107: 1193-1198
47. Kessler R, Faller M, Fourgaut G et al. Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: 219-224
48. Dierkesmann R, Gillissen A, Lorenz Jet al. Beurteilungs- und Prognosekriterien bei COPD [Assessment and outcome parameters in COPD]. Pneumologie 2009; 63: 49-55
49. Jones PW. Health status and the spiral of decline. COPD 2009; 6: 59-63
50. Oga T, Nishimura K, Tsukino M et al. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007; 101: 146-153
51. Prescott E, Almdal T, Mikkelsen KL et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-544
52. Aniwidyaningsih W, Varraso R, Cano N et al. Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care 2008; 11: 435-442
53. Schols AM, Slangen J, Volovics L et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797
54. 2). Chest2005; 128: 657-662
55. Diaz O, Begin P, Andresen M et al. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J 2005; 26: 1016-1023
56. Diaz O, Begin P, Torrealba B et al. Effects of noninvasive ventilation on lung hyperinflation in stable hypercapnic COPD. Eur Respir J2002; 20: 1490-1498
57. Budweiser S, Heinemann F, Fischer W et al. Long-term reduction of hyperinflation in stable COPD by non-invasive nocturnal home ventilation. Respir Med 2005; 99: 976-984
58. Budweiser S, Heinemann F, Meyer K et al. Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care 2006; 51: 126-132
59. Kohnlein T, Criee CP, Kohler D et al. Multizentrische Studie: Nicht-inva- sive Beatmung bei Patienten mit schwerer chronisch obstruktiver Bronchitis und Emphysem (COPD) [Multicenter study on non-invasi- ve ventilation in patients with severe chronic obstructive pulmonary disease and emphysema (COPD)"]. Pneumologie 2004; 58: 566-569
60. Rabe KF, Hurd S, Anzueto et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 532-555
61. Schucher B, Magnussen H. Beatmung bei chronisch ventilatorischer Insuffizienz [Mechanical ventilation in chronic ventilatory insufficiency]. Pneumologie 2007; 61: 644-652
62. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report. Chest 1999; 116: 521-534
63. Grant BJB, Saltzman AR. Respiratory functions ofthe lung. In: Baum GL, Wolinsky E (Hrsg) Textbook of pulmonary diseases. New York, NY: Lippincott Williams and Wilcins, 1993: 202
64. Chu CM, Chan VL, Lin AW et al. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59: 1020-1025
65. Budweiser S, Hitzl AP, Jorres RA et al. Impact of non-invasive home ventilation on long-term survival in chronic hypercapnic COPD - a prospective observational study. Int J Clin Pract 2007; 61: 1516-1522
66. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001; 163: 540-577
67. Jones SE, Packham S, Hebden M et al. Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long-term follow up and effect on survival. Thorax 1998; 53: 495-498
68. Ferrer M, Valencia M, Nicolas JM et al. Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial. Am J Respir Crit Care Med 2006; 173: 164-170
69. Nava S, Ambrosino N, Clini E et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med 1998; 128: 721-728
70. Heinemann F, Roesch F, Budweiser S et al. Home mechanical ventilation in the post weaning period: long-term results in difficult-to-wean-patients with COPD. Eur Resp J Suppl 2008; 330s: P1940
71. Quinnell TG, Pilsworth S, Shneerson JM et al. Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning results, survival, and the role of noninvasive ventilation. Chest 2006; 129: 133-139